| Date | Title | Description |
| 13.03.2023 | Intrinsic Semiconductor Technologies secures £7m investment ... | |
| 08.03.2023 | Orchard Therapeutics announces strategic financing totalling... | |
| 15.02.2023 | Girl born with MLD cured after receiving gene therapy treatm... | |
| 13.02.2023 | Freeline announces the closing of sale of its CMC-focused Ge... | |
| 06.02.2023 | First heart patients diagnosed using technology developed by... | |
| 02.02.2023 | World Cancer Day 2023 | |
| 02.02.2023 | World Cancer Day 2023 - Q&A with Amit Nathwani | |
| 01.02.2023 | Bloomsbury Genetic Therapies announces Orphan Drug Designati... | |
| 20.01.2023 | Freeline publishes preclinical proof-of-concept data for FLT... | |
| 10.01.2023 | Q&A with Mark Dickinson, CEO, Intrinsic | |
| 09.01.2023 | NovalGen appoints Dr Michael Owen and Mr Scott Clarke to the... | |
| 19.12.2022 | Achilles Therapeutics presents encouraging Phase I/IIa updat... | |
| 15.12.2022 | Vodafone Group partners with Hazy to roll out synthetic data | |
| 17.11.2022 | Apollo Therapeutics and The Institute of Cancer Research ent... | |
| 07.11.2022 | Carbon Re raises £4.2m seed funding to tackle gigatonnes of ... | |
| 03.11.2022 | NovalGen announces one oral and two poster presentations at ... | |
| 06.10.2022 | Bloomsbury Genetic Therapies launches with Seed financing of... | |
| 06.10.2022 | Bloomsbury Genetic Therapies launches with Seed financing of... | |
| 20.09.2022 | MeiraGTx’s industry-leading gene therapy manufacturing facil... | The facility, online since earlier this year and stretching over 150,000 square feet, is the first c... |
| 08.09.2022 | Death of Her Majesty, Queen Elizabeth II | |
| 28.07.2022 | Investor Q&A: Leigh Brody | |
| 28.07.2022 | Humanloop completes $2.6m seed funding round | |
| 27.07.2022 | Meet Sebastian Hunte, UCLTF Investor | |
| 21.07.2022 | Freeline Therapeutics could reduce bleeding risk for haemoph... | |
| 14.07.2022 | UCL Technology Fund Showcase 2022 | Dr Anne Lane (CEO, UCL Business and UCLTF) and Dr Andrew Elder (Partner, AlbionVC and UCLTF) welcome... |
| 27.06.2022 | Carbon Re and Materials Processing Institute join forces for... | Carbon Re announced on Tuesday 28th June its collaboration with the Materials Processing Institute t... |
| 23.06.2022 | KIT-AR announces €2m in seed stage funding round | This investment was co-led by Armilar Venture Partners and Caixa Capital Risc, with participation fr... |
| 27.05.2022 | NovalGen announces compelling data from the Phase 1/2 Study ... | |
| 26.05.2022 | NovalGen announces compelling data from the Phase 1/2 Study ... | |
| 30.03.2022 | Investor Q&A: Simon Goldman | |
| 14.03.2022 | International Women's Day 2022 | |
| 02.03.2022 | Epsilogen announces completion of oversubscribed £30.75m Ser... | |
| 28.02.2022 | We're hurtling towards a computing impasse - the investments... | |
| 14.02.2022 | Bramble Energy secures £35 million to fund its game changing... | |
| 02.02.2022 | Meet Pauline Stasiak, UCLTF Investor | |
| 28.01.2022 | G-quadruplex licence showcases the UCLTF’s unique commercial... | |
| 19.01.2022 | Qualigen Therapeutics secures worldwide rights to G4-selecti... | Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing treatments... |
| 12.01.2022 | UCLTF's Fund Managers share their trend predictions for 2022 | |
| 11.01.2022 | The rise of deeptech investments speak to an industry brimmi... | |
| 01.12.2021 | Investor Q&A: Tanel Ozdemir | |
| 30.11.2021 | Quell Therapeutics raises $156 million in oversubscribed Ser... | |
| 19.11.2021 | UCLTF Webinar: The state of early-stage Climate Tech investi... | Our webinar, 'The state of early-stage Climate Tech investing' offered a fascinating insight into Cl... |
| 21.10.2021 | On not downclimbing: the state of the biotech market | |
| 20.10.2021 | UCLTF invests in Carbon Re, a spinout helping energy-intensi... | The £1m investment has been secured from the Clean Growth Fund, alongside UCL Technology Fund (manag... |
| 17.08.2021 | Phasecraft improves Hamiltonian simulation algorithms for ne... | |
| 10.08.2021 | Bringing immuno-oncology cell therapies to the masses – are ... | |
| 03.08.2021 | David Grimm talks to Startup Dads podcast | |
| 06.07.2021 | UCLTF Showcase 2021 - The Highlights | Our 2021 UCLTF showcase saw a range of academics from our portfolio companies discuss their journeys... |
| 21.06.2021 | A Window to the Past: Is the Biotech Investment Boom Going t... | |
| 17.06.2021 | UCL, Imperial College London and University of Cambridge are... | |
| 08.06.2021 | NovalGen doses first patient in Phase I study in Chronic Lym... | London, United Kingdom, June 9, 2021 – NovalGen Ltd (“NovalGen”), a clinical stage biopharmaceutical... |
| 19.05.2021 | NovalGen presents data at American Society of Clinical Oncol... | |
| 13.05.2021 | UCL Technology Fund secures partnership with Viralgen, leadi... | |
| 07.04.2021 | NovalGen receives CTA approval to start a Phase 1/2 first in... | London, United Kingdom, 7 April 2021 – NovalGen Ltd (“NovalGen”), a biopharmaceutical company develo... |
| 31.03.2021 | Achilles Therapeutics Announces Pricing of Initial Public Of... | |
| 29.03.2021 | Over the Hill and (still) far away for UK biotech companies | |
| 25.03.2021 | MedNous interviews Professor Amit Nathwani | Read the article here: |
| 22.03.2021 | Intrinsic closes £1.35m seed funding round to prototype next... | |
| 11.03.2021 | Want to build a deeptech startup? Throw out the VC playbook | Building a startup isn’t easy. Despite the vast number of business births each year, business deaths... |
| 08.03.2021 | International Women’s Day 2021 – Meet Leigh Brody, UCLTF Inv... | |
| 25.02.2021 | Renowned Geneticist Philip Beales Launches Axovia Therapeuti... | Axovia Therapeutics, an innovative gene therapy company developing disease-transformative medicines ... |
| 22.02.2021 | Why you should consider manufacturing from the start of the ... | |
| 22.02.2021 | NovalGen enters strategic partnership with HALIX B.V. to man... | |
| 11.02.2021 | Quell Therapeutics Expands Series A Financing to $84 Million | |
| 08.01.2021 | UCL Technology Fund talks to the PanAngium team | - |
| 04.01.2021 | Platform technologies: going deep to go wide | University researchers developing cool new platform technologies often have a wide range of funding ... |
| 11.12.2020 | Phasecraft announces largest seed funding round for a UK qua... | |
| 02.12.2020 | UCL Technology Fund talks to co-founders of Echopoint about ... | - |
| 27.11.2020 | Third Space Learning raises £4.3m Series-A extension and ann... | |
| 18.11.2020 | Nozzle.ai raises $2.6m to accelerate adoption of AI platform... | |
| 27.10.2020 | UCL Technology Fund and Orchard Therapeutics: from idea to N... | - |
| 27.10.2020 | An evolution in early stage gene therapy funding models | A tsunami of curative gene therapies for rare diseases will get through pivotal trials in the coming... |
| 23.09.2020 | We are recruiting a Life Sciences Investor for the UCL Techn... | |
| 07.08.2020 | Freeline Therapeutics makes its NASDAQ debut | Freeline is a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy com... |
| 04.08.2020 | Bramble energy secures significant new capital to accelerate... | |
| 03.08.2020 | UCL Technology Fund announces first close of £100m Fund 2 | |
| 29.07.2020 | Humanloop raises funding to teach AI to learn from humans fa... | |
| 18.06.2020 | UCL engineering cancer antibody therapies for Covid-19 | A new project, led by Dr Martin Pule, Senior Lecturer in Haematology and Professor Kerry Chester, De... |
| 20.04.2020 | Epsilogen Announces £3m Series A2 financing and licences MOv... | Epsilogen has also announced that it has in-licenced exclusive global rights to MOv18 IgE, an anti-f... |
| 24.03.2020 | AstronauTx secures UCLTF investment for dementia therapeutic... | Simon Goldman, Investment Manager for the UCL Technology Fund said: |
| 17.10.2019 | Portfolio company Astroscreen featured in the Evening Standa... | Ali Tehrani, CEO of Astroscreen, says creating the tools to fight disinformation online is the new a... |
| 23.09.2019 | Quell Therapeutics makes FierceBiotech's 2019 Fierce 15 | Formed earlier this year, UCLTF portfolio company, Quell Thereapeutics was established with the aim ... |
| 16.09.2019 | Echopoint raises £2.8m to address the ‘grey zone’ of heart d... | Coronary heart disease is a major cause of death worldwide and more than 7 million* people have a di... |
| 09.09.2019 | Why we Invested in Quantum Computing start-up Phasecraft | From an investor’s perspective, the gargantuan potential of quantum computing is magnetic, but there... |
| 04.09.2019 | Orchard Therapeutics Announces Update from POC Study of OTL-... | MPS-I is a progressive and often life-threatening inherited lysosomal storage disorder affecting chi... |
| 04.09.2019 | Achilles Therapeutics raises £100m in Series B | Proceeds from this financing will deliver two human proof-of-concept studies using a unique personal... |
| 27.08.2019 | UCL’s Centre for Amyloidosis and Acute Phase Proteins publis... | Stabilisation of the circulating protein transthyretin is a key approach for preventing its breakdow... |
| 01.08.2019 | Funding academic innovations in advanced therapies: an inter... | - |
| 20.06.2019 | 2019 Brochure | The UCL Technology Fund provides both financial and direct, hands-on support for the commercialisati... |
| 18.06.2019 | Andrew Elder on healthtech investing | You can listen to the full podcast here. |
| 17.06.2019 | UCL Technology Fund Showcase 2019 | We would also like to thank our wonderful guest speakers for taking the time to showcase their innov... |
| 11.06.2019 | Hazy wins 'Best Innovation in Data Protection & Privacy' | A huge congratulations to the team at Hazy for winning the 'Best Innovation in Data Protection &... |
| 29.05.2019 | Fund leads £750k investment in Phasecraft | Phasecraft, cofounded by academics at UCL and the University of Bristol, is developing software for ... |
| 20.05.2019 | UCLTF completes £1m investment into Quell Therapeutics as pa... | Syncona announces the foundation of Quell Therapeutics, a new cell therapy company, with a £35 milli... |
| 30.04.2019 | UCLTF nominated for 'Investment Unit of the Year' | The winners will be revealed at the gala dinner on May 22 as part of our GUV: Fusion conference, run... |
| 30.04.2019 | Odin Vision scales up its cancer detection technology | The company, led by Peter Mountney and Danail Stoyanov (UCL Computer Science), is developing a revol... |
| 18.04.2019 | Astroscreen raises $1m to detect social media manipulation | The funding round was led by Speedinvest, UCL Technology Fund, which is managed by AlbionVC in colla... |
| 16.04.2019 | Data Supports Achievement of Proof-of-Concept Milestone for ... | Orchard Therapeutics has announced the achievement of clinical proof-of-concept based on data from t... |
| 28.02.2019 | Orchard Therapeutics achieves 100% survival rate during tria... | ADA-SCID is a rare, life-threatening, inherited disease caused by mutations in the ADA gene. Patient... |
| 03.12.2018 | Hazy included in Forbes '15 Machine Learning Companies To Wa... | Hazy is an AI spin-out from UCL and is one of the businesses invested in by the UCL Technology Fund ... |